R Mordasini

1.4k total citations
68 papers, 1.1k citations indexed

About

R Mordasini is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, R Mordasini has authored 68 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Surgery, 20 papers in Endocrinology, Diabetes and Metabolism and 13 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in R Mordasini's work include Lipoproteins and Cardiovascular Health (31 papers), Pharmacology and Obesity Treatment (12 papers) and Cancer, Lipids, and Metabolism (12 papers). R Mordasini is often cited by papers focused on Lipoproteins and Cardiovascular Health (31 papers), Pharmacology and Obesity Treatment (12 papers) and Cancer, Lipids, and Metabolism (12 papers). R Mordasini collaborates with scholars based in Switzerland and Germany. R Mordasini's co-authors include P Weidmann, Walter Riesen, Gerald Klose, Andreas Gerber, Walter F. Riesen, C. Bachmann, Felix J. Frey, Heiner Greten, P. Oster and H. P. Gurtner and has published in prestigious journals such as New England Journal of Medicine, American Journal of Clinical Nutrition and Hypertension.

In The Last Decade

R Mordasini

65 papers receiving 971 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R Mordasini Switzerland 18 511 412 348 194 169 68 1.1k
A. van ‘t Laar Netherlands 19 576 1.1× 468 1.1× 319 0.9× 99 0.5× 147 0.9× 39 1.3k
L. A. Carlson Sweden 18 502 1.0× 433 1.1× 299 0.9× 103 0.5× 229 1.4× 33 1.3k
Richard P. Ames United States 20 646 1.3× 256 0.6× 735 2.1× 235 1.2× 220 1.3× 36 1.5k
Gerald J. Brook Israel 17 364 0.7× 381 0.9× 306 0.9× 75 0.4× 232 1.4× 48 1.5k
J M Warnet France 12 981 1.9× 350 0.8× 432 1.2× 73 0.4× 206 1.2× 14 1.4k
Thomas Littlejohn United States 22 601 1.2× 392 1.0× 607 1.7× 222 1.1× 172 1.0× 43 1.4k
Anders Gustafson Sweden 21 671 1.3× 485 1.2× 256 0.7× 98 0.5× 290 1.7× 48 1.7k
K Kuba United States 13 436 0.9× 364 0.9× 166 0.5× 59 0.3× 250 1.5× 20 1.1k
Avedis K. Khachadurian United States 25 558 1.1× 595 1.4× 271 0.8× 66 0.3× 359 2.1× 60 1.8k
Kenneth G. Berge United States 14 974 1.9× 1.2k 2.8× 461 1.3× 152 0.8× 191 1.1× 27 1.9k

Countries citing papers authored by R Mordasini

Since Specialization
Citations

This map shows the geographic impact of R Mordasini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Mordasini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Mordasini more than expected).

Fields of papers citing papers by R Mordasini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R Mordasini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Mordasini. The network helps show where R Mordasini may publish in the future.

Co-authorship network of co-authors of R Mordasini

This figure shows the co-authorship network connecting the top 25 collaborators of R Mordasini. A scholar is included among the top collaborators of R Mordasini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R Mordasini. R Mordasini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Eckardstein, Arnold von, Walter F. Riesen, David Carballo, et al.. (2018). Empfehlungen zur Prävention der Atherosklerose 2018: Update der AGLA. Swiss Medical Forum ‒ Schweizerisches Medizin-Forum. 2 indexed citations
2.
Riesen, Walter F. & R Mordasini. (2008). Update der lipidsenkenden Therapie. Praxis. 97(22). 1179–1184. 1 indexed citations
3.
Noseda, G, et al.. (2000). [Evaluating the efficacy and tolerance of atorvastatin in hyperlipidemia in general practice (SWITCH Study)].. PubMed. 130(23). 889–95. 6 indexed citations
4.
Gerber, Andreas, P Weidmann, Mario G. Bianchetti, et al.. (1985). Serum lipoproteins during treatment with the antihypertensive agent indapamide.. Hypertension. 7(6_pt_2). II164–9. 23 indexed citations
5.
Mordasini, R, et al.. (1984). [Traumatic rupture of the Achilles tendon and hyperlipidemia].. PubMed. 87(5). 226–9. 8 indexed citations
6.
Mordasini, R, P. Oster, & Walter Riesen. (1982). Dietary and drug treatment of hyperlipoproteinemia. La Ricerca in Clinica e in Laboratorio. 12(1). 117–25. 1 indexed citations
7.
Weidmann, P, et al.. (1982). [Diuretic treatment and serum lipoproteins: effects of tienilic acid and indapamide (author's transl)].. PubMed. 71(7). 289–92. 3 indexed citations
8.
Mordasini, R, Walter Riesen, & P. Oster. (1981). [HDL--the unknown with great significance].. PubMed. 111(9). 309–14. 2 indexed citations
9.
Meier, Andreas, et al.. (1981). [The effect of hydrochlorothiazide/amiloride alone or in combination with alpha-methyldopa on serum lipoproteins].. PubMed. 111(15). 525–30. 13 indexed citations
10.
Meier, Andreas, Helmut Schiffl, P Weidmann, et al.. (1981). β-Receptor-Blocking Agents May Reverse or Prevent Diuretic-Induced Increases in Serum Low-Density Lipoprotein Cholesterol. Clinical Science. 61(s7). 437s–439s. 9 indexed citations
11.
Riesen, Walter, Markus A. Keller, & R Mordasini. (1980). Probucol in hypercholesterolemia *1A double blind study. Atherosclerosis. 36(2). 201–207. 31 indexed citations
12.
Mordasini, R & Walter F. Riesen. (1980). Electroimmunoassay and Radioimmunoassay for the Quantitation of High Density Apolipoproteins A-I and A-II. Clinical Chemistry and Laboratory Medicine (CCLM). 18(12). 917–920. 2 indexed citations
13.
Mordasini, R, et al.. (1980). Zur Pathogenese der Diuretika-induzierten Hyperlipoprotein�mie. Journal of Molecular Medicine. 58(7). 359–363. 14 indexed citations
14.
Mordasini, R, et al.. (1979). [Effect of the lipid-lowering agent, procetofen, on the makeup of human biliary lipids].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 109(16). 601–2. 6 indexed citations
15.
Glück, Z., P Weidmann, R Mordasini, et al.. (1979). [The effect of diuretic therapy on serum lipoproteins: an undesirable effect?].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 109(4). 104–8. 15 indexed citations
16.
Mordasini, R, et al.. (1978). [A comparative study of colestipol and colestyramine in children and adolescents with familial hypercholesterolaemia (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 126(7). 436–40. 9 indexed citations
17.
Mordasini, R, et al.. (1978). Medikament�se Behandlung prim�rer Hyperlipoprotein�mien. Journal of Molecular Medicine. 56(3). 99–110. 6 indexed citations
18.
Oster, P., et al.. (1977). [Complications in null-diet].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 107(38). 1313–7. 3 indexed citations
19.
Mordasini, R, et al.. (1977). Selective Deficiency of Hepatic Triglyceride Lipase in Uremic Patients. New England Journal of Medicine. 297(25). 1362–1366. 129 indexed citations
20.
Mordasini, R, et al.. (1975). [Lipoprotein X in hepatobiliary diseases].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 105(27). 863–72. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026